Optometrists in Kihei, HI Accepting Medicare

6 Optometrists found. Showing 1 - 6

Diane Santesson Od Inc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 380 Huku Lii Pl, Ste. 107, Kihei, HI 96753 Phone: 808-875-4466

Deidrie J Colter, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1279 S Kihei Rd Ste 120, Kihei, HI 96753 Phone: 808-891-6800

Cheryl E. Ayabe, O.d., Inc. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1280 S Kihei Rd Ste 204, Kihei, HI 96753 Phone: 808-879-7788

Alicia Van, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 380 Huku Lii Pl, Suite #107, Kihei, HI 96753 Phone: 808-875-4466    Fax: 808-874-3899

Aloha Eye Clinic, Ltd. Optometrist Medicare: Medicare Enrolled Practice Location: 1300 N Holopono St Ste 109, Kihei, HI 96753 Phone: 808-877-3984

Eye Gallery Inc Optometrist Medicare: Medicare Enrolled Practice Location: 380 Huku Lii Pl, Suite 107, Kihei, HI 96753 Phone: 808-875-4466    Fax: 808-874-3899

News Archive

MRI-based models can help reduce unnecessary biopsies in suspected prostate cancer patients

In a collaborative, multi-institutional study published by JAMA Oncology, researchers from the University of Alabama at Birmingham, University of Chicago, and National Cancer Institute determined that MRI-based prediction models can help reduce unnecessary biopsies in suspected prostate cancer patients and help improve personalized risk stratification.

Euroscience deeply concerned over governments' proposed cuts in research investment

Across the European Union and the wider Europe, governments are engaged in cutting public expenditure and we are entering an unprecedented period of austerity. Thus, public support for research is now at risk in a manner not seen before and just at the time when Europe faces new challenges from the rising new economies, especially in Asia, and when threats to our quality of life from climate change, demographic change and energy, food and resource availability and sustainability are becoming evermore threatening and urgent.

Shire announces Phase IIIb study results of Daytrana

Shire plc, the global specialty biopharmaceutical company, today announced findings at a major medical meeting from a Phase IIIb study of the tolerability and effectiveness of Daytrana® (methylphenidate transdermal system) in adolescents aged 13 to 17 years diagnosed with Attention-Deficit/Hyperactivity Disorder (ADHD).

Collaboration of public and private health partners is essential for health improvement

Improving health is too multifaceted to be left solely in the hands of those working in the health sector alone, according to the latest Healthy People 2020 Objectives for the Nation. A recent shift in national health priorities has led Healthy People, a program that sets the national agenda for health promotion and disease prevention, to add 'social determinants' into its 2020 goals.

Identigene announces availability of DNA paternity test kit in New York drug stores

Identigene today announced that the Identigene DNA Paternity Test Kit is now available in chain drug stores and independent pharmacies throughout the state of New York, expanding sales from 260 retail locations in the New York City area to more than 1,600 stores across the state.

Read more Medical News

› Verified 9 days ago